Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

A 27-year-old male with AGA and diffused thinning has been using oral Minoxidil, Finasteride, Vitamin D, B12, Iron, and Ketoconazole shampoo. Despite a hair transplant and improved blood levels, he continues to experience hair loss and suspects a possible misdiagnosis of Alopecia Areata Incognita.

Many people become hyper-aware of hair loss in themselves and others, often leading to feelings of jealousy or self-consciousness. Treatments like finasteride, minoxidil, and dutasteride are commonly discussed as solutions to combat hair loss.

A 42-year-old experienced significant hair regrowth after 12 weeks on an oral combination of finasteride (1 mg) and minoxidil (2.5 mg), with noticeable improvements and no side effects. The user is considering continuing the treatment for a year due to the unexpected positive results.

The user started finasteride on August 12 and experienced increased energy, confidence, and motivation, attributing these changes to either the medication or lifestyle changes. Others shared mixed experiences with finasteride, noting both positive effects and potential negative side effects, with some attributing improvements to increased testosterone levels.

Some users attribute erectile dysfunction (ED) to finasteride, but others suggest porn use or other factors might contribute. There are mixed opinions on finasteride's side effects, with some experiencing mental health issues and others defending its use for hair loss.

A 32-year-old male shares his 5-year progress using finasteride, minoxidil, RU58841, and ketoconazole for hair loss. Despite consistent use, he feels his hair isn't as thick as before and is concerned about continued shedding and hairline miniaturization.

Caffeine might raise stress hormones, potentially worsening hair loss. Telogen effluvium is often misattributed to minor stressors rather than significant life events.

A 25-year-old is using oral finasteride (1mg) and oral minoxidil (0.25mg) for hair loss, experiencing improved mental health and no significant side effects. Others in the conversation discuss their experiences with similar treatments, dosages, and side effects.

The user has mostly recovered hair density using finasteride, alternating oral and topical minoxidil, and occasional dermarolling, but the crown area is still struggling. Advice includes continuing treatment for up to 24 months and possibly consulting a doctor if issues persist.

The user regrets not starting finasteride at 1 mg daily from the beginning, as they feel their initial microdosing was ineffective. They are now on the standard dosage and hope to see improvements in hair loss over the next few months.

A 22-year-old male experiencing diffuse hair thinning has been using finasteride, initially at 0.5mg and then 1mg daily, but sees no improvement. Despite correcting a vitamin D deficiency and noticing some new hair growth, he questions the effectiveness of finasteride.

The conversation discusses the side effects of finasteride, including low libido and erectile dysfunction, and the possibility of these effects being permanent, known as post-finasteride syndrome (PFS). Some users report personal experiences with PFS and debate whether the condition is real, with varying opinions on the reversibility of side effects and the role of individual biology.

Finasteride can cause sexual side effects, and reducing porn and masturbation may help improve sexual function. Some users experience persistent issues even after stopping finasteride.

Finasteride may take over two years to show results and can cause side effects like sexual dysfunction and emotional changes. Alternatives such as dutasteride and minoxidil are discussed, with varying effectiveness and side effects.

SCUBE3 and Amplifica's progress in hair loss treatment is being discussed, with inquiries about their current status and clinical trials. No specific updates or new information are provided in the conversation.

Finasteride's potential side effects, especially sexual dysfunction, are discussed, with emphasis on hormonal balance between testosterone and estradiol. Users share experiences with finasteride, minoxidil, and dutasteride, highlighting the variability in side effects and the influence of mindset and lifestyle.

Clascoterone solution is in Phase III trials for male androgenetic alopecia, with results expected in the second half of 2025. Commercialization is anticipated in about 2-3 years, but there are concerns about delays and market expectations.

The user started using oral finasteride and minoxidil a year ago and is questioning if there's improvement in hair regrowth. Responses indicate noticeable improvement and suggest the user caught hair loss early, likely returning to their peak hair condition.

The user has been using finasteride for 5 months to address hair loss and is unsure if progress is being made despite ongoing shedding. Other users believe there is visible improvement and encourage continued use.

The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.

The conversation is about managing side effects of finasteride for hair loss, with users discussing splitting 1mg pills into 0.5mg doses to reduce fatigue and other side effects. Some users experienced initial side effects like fatigue and heart palpitations, which improved over time or with dose adjustments.

A user experienced reduced stress and improved hair appearance after getting a buzzcut while using finasteride, minoxidil, and microneedling. The user feels the haircut and treatments may have improved hair quality and filled in patchy areas.

A person is struggling with hair loss despite using finasteride and minoxidil, considering dutasteride and magnesium supplements. They are advised to be patient, consider a hair transplant, and check for thyroid issues.

The conversation discusses hair loss treatments, including minoxidil, finasteride, biotin, folic acid, zinc, micro-needling, niacin, and cipaxil, with the user preparing for a hair transplant. The user experiences side effects with topical finasteride and is hesitant to try oral dutasteride.

The conversation humorously discusses the fictional "Post PP405 Syndrome" and the idea of starting a foundation or cult around it. It mentions skepticism about the effectiveness of PP405 and jokes about future therapies.

After 13 years on finasteride, OP is experiencing reduced effectiveness and has started taking 0.5 mg of dutasteride weekly, noticing nipple sensitivity as a side effect. OP plans to increase the dutasteride dosage and retest hormone levels, while others suggest adjusting the dosage or trying different forms of dutasteride.

The conversation discusses the potential updates on the pp405 trial for hair loss, with completion expected by December 2025. Participants express skepticism about new treatments, suggesting continued use of finasteride, while others hope for innovative solutions beyond current medications.

A 23-year-old shares insights on hair perception, emphasizing that angles and hair manipulation can alter appearance, and advises focusing on natural views. The discussion highlights the importance of hair density over hairline perfection.

Finasteride is effective for hair loss but can cause sexual dysfunction and mental health issues in some users, leading to a polarized debate on its risks. Some switch to alternatives like Dutasteride or topical treatments to avoid side effects.

The conversation discusses a botanically derived treatment for androgenetic alopecia using ingredients like saw palmetto, green tea, and evening primrose, showing impressive results over 270 days. Concerns include the study's uncontrolled nature and potential product motivation, with suggestions to enhance absorption through derma rolling.